Radiopharm Theranostics Limited
RADX institutional ownership changes in Q2 2026: 3 institutions opened or added positions, 1 trimmed or exited. RADX (Radiopharm Theranostics Limited) is held by 4 institutional investors as of Q2 2026. Top institutional shareholders: HSBC Holdings plc ($253,727), PNC Financial Services Group, Inc. ($83,800), UBS Group AG ($6,314). Net institutional sentiment: Bullish.
Who's Trading
Latest move
Source dates: Price Nov 5, 2026 · Insiders none · Activists Oct 14, 2026 · Congress none
Top Holders
| Action | ||||||
|---|---|---|---|---|---|---|
Increased | 62,188(+1.3%) | $253,727 | 0.0% | -82.91% | 23 | |
Increased | 20,000(+25.0%) | $83,800 | 0.0% | -81.84% | 18 | |
Decreased | 1,507(-49.8%) | $6,314 | 0.0% | -80.91% | 0 | |
Increased | 195(+61.2%) | $817 | 0.0% | -79.24% | 11 |
RADXRadiopharm Theranostics LimitedContinue exploring
Other Healthcare stocks held by institutions
UNHUnitedHealth Group Incorporated
LLYEli Lilly and Company
TMOThermo Fisher Scientific Inc
JNJJohnson & Johnson
DHRDanaher Corporation
ISRGIntuitive Surgical, Inc.
MRKMerck & Company, Inc.
ABBVAbbVie Inc.
BSXBoston Scientific Corporation
ABTAbbott LaboratoriesQuestions investors ask about RADX
Who owns RADX?
4 institutional investors held RADX on June 30, 2026, led by HSBC Holdings plc ($253,727), PNC Financial Services Group, Inc. ($83,800) and UBS Group AG ($6,314).
How many hedge funds hold RADX?
4 institutional investors reported RADX in their 13F filings for the quarter ended June 30, 2026, $344,658 in all. One of them is rated Elite.
Are institutions buying or selling RADX?
Buying, on balance. In Q2 2026, 3 institutions opened or added to positions in RADX and 1 institution trimmed or exited.
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer